MRNA - Moderna, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 51.81B
Enterprise Value 43.11B
Trailing P/E 6.47
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.87
Price/Book (mrq)2.62
Enterprise Value/Revenue 2.91
Enterprise Value/EBITDA 8.06

Trading Information

Stock Price History

Beta (5Y Monthly) 1.69
52-Week Change 3-6.29%
S&P500 52-Week Change 32.74%
52 Week High 3217.25
52 Week Low 3115.03
50-Day Moving Average 3139.52
200-Day Moving Average 3153.94

Share Statistics

Avg Vol (3 month) 33.4M
Avg Vol (10 day) 33.67M
Shares Outstanding 5381.21M
Implied Shares Outstanding 6N/A
Float 8344.03M
% Held by Insiders 19.61%
% Held by Institutions 168.33%
Shares Short (May 14, 2023) 418.22M
Short Ratio (May 14, 2023) 45.02
Short % of Float (May 14, 2023) 46.36%
Short % of Shares Outstanding (May 14, 2023) 44.78%
Shares Short (prior month Apr 13, 2023) 416.7M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin 31.77%
Operating Margin (ttm)32.05%

Management Effectiveness

Return on Assets (ttm)11.66%
Return on Equity (ttm)26.62%

Income Statement

Revenue (ttm)15.06B
Revenue Per Share (ttm)38.61
Quarterly Revenue Growth (yoy)-69.30%
Gross Profit (ttm)10.55B
Net Income Avi to Common (ttm)4.78B
Diluted EPS (ttm)11.94
Quarterly Earnings Growth (yoy)-97.80%

Balance Sheet

Total Cash (mrq)8.92B
Total Cash Per Share (mrq)23.41
Total Debt (mrq)1.11B
Total Debt/Equity (mrq)5.87
Current Ratio (mrq)3.46
Book Value Per Share (mrq)49.12

Cash Flow Statement

Operating Cash Flow (ttm)993M
Levered Free Cash Flow (ttm)541.88M